Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
In the face of senators' criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company's Covid-19 vaccine in a hearing Wednesday on the vaccine's price.
"Truth is, [the] pharmaceutical industry is enormously greedy, charging us outrageously, uncontrollably high prices," the senator told "Face the Nation."
Recent small studies, not yet peer-reviewed, suggested the new boosters may not be significantly better than the original vaccine formula.
The federal budget for buying and distributing COVID-19 vaccines will run out "as early as January."
